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INTRODUCTION
Asthma is a multifactorial disease characterized by chronic
inflammation in the lungs. The signature of the disease is mas-
sive infiltration of the bronchial mucosa by several cell types
including lymphocytes, eosinophils, and mast cells, which is
accompanied by a pronounced elevation in serum IgE. Desqua-
mation of the lung epithelium occurs, along with goblet cell
hyperplasia, thickening of the mucosal layer, and mucus pro-
duction within the bronchioles, with the overall result being
impeded airflow and airway hyperreactivity (AHR) (1).
Asthma is also defined as a complex genetic disorder with
a heterogeneous phenotype attributed to the interactions among
many genes and the environment (2). To comprehend the
pathogenetic mechanisms underlying the many variants of
asthma, it is essential to identify factors that initiate, intensify,
and modulate the inflammatory response of the airway and
to determine how these immunological and biological pro-
cesses produce the characteristic airway abnormalities (3).
The complex nature of the asthma phenotype, together with
genetic heterogeneity and environmental influences, has made
it difficult to uncover the aspects that underlie this common
disease (4). Recently, a number of factors have been reported
that might predispose or protect against asthma, but there
is no single factor which can completely explain the develop-
ment of asthma (5-10). Thus, large-scale, high-throughput,
and whole-proteome studies are needed to understand the
genetic contribution to asthma.
Two-dimensional polyacrylamide gel electrophoresis (2-
DE), which separates polypeptides by their charge (pI) and
relative molecular mass (Mr), has been shown to be a power-
ful technique for analyzing complex mixtures of proteins (11).
The improvement of two-dimensional electrophoresis by the
development of immobilized pH gradients (IPGs; 12), together
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Proteomic Analysis of Differently Expressed Proteins in a Mouse
Model for Allergic Asthma
Allergic asthma is associated with persistent functional and structural changes in the
airways and involves many different cell types. Many proteins involved in allergic
asthma have been identified individually, but complete protein profiles (proteome)
have not yet been reported. Here we have used a differential proteome mapping
strategy to identify tissue proteins that are differentially expressed in mice with aller-
gic asthma and in normal mice. Mouse lung tissue proteins were separated using
two-dimensional gel electrophoresis over a pH range between 4 and 7, digested,
and then analyzed by matrix-assisted laser desorption/ionization-time of flight mass
spectrometry (MS). The proteins were identified using automated MS data acqui-
sition. The resulting data were searched against a protein database using an inter-
nal Mascot search routine. This approach identified 15 proteins that were differen-
tially expressed in the lungs of mice with allergic asthma and normal mice. All 15
proteins were identified by MS, and 9 could be linked to asthma-related symptoms,
oxidation, or tissue remodeling. Our data suggest that these proteins may prove
useful as surrogate biomarkers for quantitatively monitoring disease state progres-
sion or response to therapy.
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with improved solubilization techniques (13, 14), now per-
mits the reproducible separation of up to 2000 proteins on
a single two-dimensional electrophoresis gel. Such gel-sepa-
rated proteins can be identified rapidly by mass spectrome-
try (MS), and, if genomic information is also available, such
analyses permit the systematic identification of the protein
complement of a genome, known as the proteome (15-18).
In this study, we have adopted a proteomics approach to bet-
ter understand the protein basis of this pathology of asthma
on the whole, and to development of marker for ovalbumin
induces asthma.
MATERIALS AND METHODS
Animals
Male BALB/c mice (5 weeks old) were obtained from Charles
River Laboratories (MA, U.S.A.) and were held under specific
pathogen-free conditions. The experiments, approved by our
institutional Committee on Animal Experimentation, were
performed in compliance with governmental and internation-
al guidelines on animal experimentation.
Sensitization and provocation procedures
The experimental mice were sensitized to ovalbumin (OVA,
Grade V; Sigma-Aldrich, St. Louis, MO, U.S.A.) on days 1
and 14 by administration of three intraperitoneal (i.p.) injec-
tions of 10  g OVA emulsified in 200  L phosphate-buffered
saline (PBS) with 1.5 mg aluminum hydroxide (Sigma-Ald-
rich). The mice were subsequently challenged with an OVA
aerosol (1% in PBS) for 20 min on days 28, 29, and 30 (Fig.
1A). The aerosol was delivered to a 9-L Perspex exposure
chamber by a nebulizer (model 646; DeVilbiss, Somerset, PA,
U.S.A.) driven by an airflow of 40 L/min, which provided
an aerosol with an output of 0.33 mL/min. The control ani-
mals received i.p. injections of aluminum hydroxide in PBS
and were subsequently challenged with PBS aerosol.
Measurement of airway hyperreactivity
Responsiveness to methacholine was assessed in conscious,
unrestrained mice by barometric plethysmography, using
an apparatus and software from All Medicus (Seoul, Korea).
The measurements were conducted using standard methods,
similar to those described previously (19). Each mouse was
placed in a plethysmograph chamber and exposed to an aerosol
of PBS for baseline readings, followed by increasing concen-
trations of aerosolized methacholine (2.5-20 mg/mL; Sigma-
Aldrich) for 3 min each. AHR was assessed using the enhanced
pause parameter (Penh), which was calculated automatically
by the software based on the mean pressure generated in the
plethysmograph chambers during inspiration and expiration,
combined with the time of each respiratory phase. Penh read-
ings were recorded for 5 min after each aerosol exposure and
averaged. The results are presented as the mean percent change
in Penh at each methacholine concentration compared with
the baseline readings, calculated from the data from groups
of six mice.
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Fig. 1. Construction of the mouse model for allergic asthma. (A) Schematic representation of ovalbumin (OVA) sensitization and challenge
protocol. (B) Airway responsiveness to methacholine in OVA-sensitized mice at 24 hr after the last challenge with saline (diamonds) or OVA
(black rectangles). The results are expressed as the arithmetic means±SEM (n=6 per group). Significant differences from saline-challenged
animals: *p<0.05; 
� p<0.01. (C) Numbers of mononuclear cells recovered in bronchial alveolar (BAL) fluid after saline or OVA challenge. Differ-
ential cell counts were performed on a minimum of 500 cells per sample to identify eosinophils (black), neutrophils (open), macrophages
(hatched), and lymphocytes (gray). Challenge with OVA significantly increased the total cell numbers. Eosinophils and macrophages recov-
ered in BAL fluid were significantly increased, whereas the neutrophil and lymphocyte counts were unchanged in OVA-challenged mice.
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Sample preparation
All reagents used in 2-DE were obtained from Amersham
Biosciences (Seoul, Korea). Fresh lung tissue was placed in a
clean mortar containing liquid nitrogen and finely ground;
1 mL of sample buffer (7 M urea, 2 M thiourea, 4% CHAPS,
40 mM Tris-HCl, 20 mM DTT, 2% IPGphore buffer) was
added and mixed thoroughly. The suspensions were sonicated
for approximately 1 hr at 4℃and centrifuged at 15,000 g for
30 min at 4℃; the supernatants were stored at -80℃until use.
Two-dimensional gel electrophoresis
2-DE was performed in a horizontal apparatus (IPGphor
and Hoefer 600 SE; Amersham Biosciences, Uppsala, Swe-
den). For the analytical gels, 200  g of protein was applied
onto immobilized pH gradient (IPG) strips (24 cm, pH 4-
7) containing Immobilines pH 4-7, thiourea, CHAPS, and
urea, according to the method of Rabilloud et al. (13). After
isoelectric focusing, the strips were applied to the top of SDS-
PAGE gels (12.5%), and the proteins were separated accord-
ing to their molecular mass. The SDS-PAGE gels were silver-
stained to detect proteins (20). For the analysis of selected
proteins after tryptic digestion, 2 mg of digested protein was
applied to the IPG strip, and the final SDS-PAGE gel was
stained using Coomassie Brilliant Blue G250 (Sigma-Aldrich).
Image analysis
Digitized images of the stained gels were analyzed using
the 2-DE gel analysis program ImageMaster 2D ver. 4.0
(Amersham Pharmacia Biotech, Uppsala, Sweden). A com-
parison report of the qualitative and quantitative differences
between the samples for each data set of was generated.
In-gel digestion and mass spectrometric analysis
Differentially expressed protein spots were excised from
the gels, cut into smaller pieces, and digested with trypsin
(Promega, Madison, WI, U.S.A.), as previously described
(21). For MALDI-TOF MS analysis, the tryptic peptides were
concentrated on POROS R2 columns (Applied Biosystems,
Foster City, CA, U.S.A.). After successive column washings
with 40% methanol, 100% acetonitrile, and 50 mM ammo-
nium bicarbonate, the samples were applied onto the R2 col-
umn and eluted in 2 mL of a-cyano-4-hydroxycinnamic acid
before MALDI-TOF analysis (22, 23). The spectra for the
protein samples were obtained using a Voyager DE PROMA-
LDI-TOF spectrometer (Applied Biosystems). The searches
of protein databases were performed with the MSFit program
(http://prospector.ucsf.edu/ucsfhtml3.4/msfit.htm) using
monoisotopic peaks. A mass tolerance within 50 ppm was
allowed for the first analysis; the system was subsequently
recalibrated at 20 ppm using the lists of proteins obtained
from the initial analysis. The spectra were also internally cali-
brated using trypsin autolysis products. The resulting peptide
masses were used to search the databases managed by SWIS-
SPROT (http://kr.expasy.org) and the National Center for
Biotechnology Information (http://www.ncbi.nlm.nih.gov).
Semiquantitative RT-PCR
Single-stranded cDNA was synthesized from 3  g of total
RNA using an oligodeoxythymidylic acid primer and Super-
script II reverse transcriptase (Invitrogen, Carlsbad, CA,
U.S.A.). Each cDNA was diluted for subsequent PCR ampli-
fication. GAPDH (glyceraldehyde 3-phosphate dehydroge-
nase) was amplified as a quantitative control. Each PCR was
carried out in a 20- L volume of 1× PCR buffer with a pro-
gram of 10 min at 94℃ for initial denaturing, followed by
26 cycles of 94℃ for 30 sec, 56℃ for 30 sec, and 72℃ for
30 sec, in a GeneAmp PCR system 9600 (Perkin-Elmer
Applied Biosystems, Foster City, CA). The following primers
were used: YM1-forward, 5′ -taccagttgggctaagga-3′ ; YM1-
reverse, 5′ -atgctggaaatcccaca-3′ ; YM2-forward, 5′ -gccattg-
gaggatggaa-3′ ; and YM2-reverse, 5′ -tggaatgtggttcaaagt.
Statistical analysis
The proteins from the asthmatic and control groups were
analyzed for differences in levels of expression using Student’s
t-test or the Mann-Whitney U-test. Values of p<0.05 were
considered significant.
RESULTS
Construction of the asthmatic mouse model
The intraperitoneal sensitization and nebulized provoca-
tion of mice with ovalbumin resulted in a dose-dependent
increase in airway responsiveness to inhaled methacholine
(Fig. 1B). The treated mice had significantly increased num-
bers of total cells in bronchoalveolar lavage (BAL) fluid, as
well as in the number and percentage of eosinophils in the
BAL fluid (Fig. 1C). Also, the levels of ovalbumin-specific
IgE were increased in the plasma of ovalbumin-challenged
asthmatic mice (data not shown).
2-DE analysis of mouse lung tissues from control and
OVA-challenged mice
To examine the differential expression of proteins in lung
tissues from asthmatic mice and normal controls, proteomic
analysis was performed using high-resolution 2-DE. Fig. 2
is a representative master gel image showing the separation
of proteins from normal mouse lung tissue. More than 1,000
protein spots with pIs between 3 and 10 and with relative582 H.S. Jeong, T.Y. Rhim, M.-H. Ahn, et al.
molecular masses between 15 and 150 kDa were detected
on the 2-DE gels. A computer-assisted comparative analysis
of the respective silver-stained spot patterns of six paired sam-
ples (six normal controls and six OVA-challenged, asthmatic
mice) showed that one protein spot appearing in the 2-DE
gels of control tissues (Fig. 2, arrows) were slightly increased
in the lung tissues of OVA-challenged mice. However, most
of the variable spots were located in two limited areas of the
gels (Fig. 2, boxed).
By conducting 2-DE using several types of IPG strips, we
found that the 4-7 pH range covers a majority of the proteins
of interest in mouse lung tissue, and thus was the best choice
Fig. 2. 2-dimension electrophoresis (DE) of proteins from normal
(Sham) and allergic asthma (OVA) mouse lung tissues. Proteins
from the whole lung were extracted and separated on an IPG strip
with a nonlinear gradient of pH 3-10, followed by separation in the
second dimension on an 8-18% SDS polyacrylamide gel. The gel
was stained with Coomassie Blue G-250. Spots 1 was determined
to be transthyretin.
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Fig. 3. 2-DE of proteins from normal (Sham) and allergic asthma
(OVA) mouse lung tissues. In the first dimension, proteins were
loaded on a 24-cm IPG strip with a linear gradient of pH 4-7. A 12%
SDS polyacrylamide gel was used for second dimension separa-
tion. Proteins were visualized by silver staining. Indicated spots
represent proteins differentially expressed between normal and
asthmatic lung tissues.
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Fig. 4. Protein expression levels were determined by relative intensity using image analysis. Normalized spot intensities of the asthma ver-
sus normal control (sham) group were compared. Mean intensity and spot intensities on individual gels are shown. *p<0.05, 
� p<0.01, 
� p<
0.001 by Student’s t-test.for initial survey investigations (data not shown). In order to
preselect proteins exhibiting variations in expression levels,
the protein patterns from asthmatic and control lung tissues
were divided into two classes, and the quantities of all detect-
ed spots in both classes were compared by Student’s t-test
using ImageMaster 2-DE gel analysis software. After com-
paring the 2-DE protein patterns on duplicate gels of lung
tissue from six asthmatic and six control mice, we found 14
protein spots that were significantly different in asthmatic
and control tissues (Fig. 3). Among them, eight spots were
meaningfully increased, and five spots were decreased in the
lungs of OVA-challenged mice (Fig. 4). Two protein spots
were exclusively expressed in asthmatic lung tissues (Fig. 3,
spots 10 and 15).
Protein identification
The protein spots that revealed statistically significant dif-
ferences between asthmatic mice and normal controls were
excised from the gels, trypsinized, and analyzed by MALDI-
TOF MS. Of these, we have been able to identify 16 proteins
(Table 1). The number of matching peptides, the percentage
of sequence coverage, and the accuracy of mass estimates were
used to evaluate the database search results. Trypsin autolysis
peaks were regularly used for internal calibration of the mass
spectra to achieve a 50 ppm mass accuracy. Also, in most cases
the apparent Mr and pI determined from the 2-DE protein
pattern were in agreement with the theoretical values of the
identified proteins.
Differential expression of YM1 and YM2 genes
To determine whether the up-regulation of YM1 and YM2
expression occurred at the mRNA level, we performed semi-
quantitative RT-PCR analysis (Fig. 5) using YM1- and YM2-
specific primers. The results confirmed that the mRNAs of
YM1 and YM2 were expressed at very low levels in normal
mouse lung tissue (Fig. 5, SHAM), and were present at con-
siderably higher levels in the lungs of asthmatic mice (Fig. 5,
OVA). These results substantiate the specific up-regulation
of YM1 and YM2 expression in the lungs of asthmatic mice
compared with those of normal mice.
DISCUSSION
In this report, we present the comparative proteome anal-
ysis of normal and asthmatic lung tissues from mice. The pH
ranges used for the first-dimension gel electrophoresis in this
study (3-10 and 4-7) separated a proportion of the soluble
proteins in the lung tissues, allowing a focus on the high-res-
olution, more unambiguous comparison of proteins with iso-
electric points between pH 4 and 7.
To avoid individual and experimental variation, we pro-
duced a large number of replicate gels from the same sample
or treatment group in order to obtain statistically significant
changes in protein levels between the different groups, i.e.,
asthma versus normal. Using 2-DE, we found 15 proteins
that were differentially expressed in the lung tissues of mice
with OVA-induced allergic asthma. Five protein spots were
down-regulated and eight protein spots were up-regulated
in asthmatic lungs compared with normal lung. These pro-
tein spots were identified by in-gel digestion and MALDI-
TOF MS.
The identified proteins could be classified into three differ-
ent groups based on their cellular functions and participation
in biochemical pathways. Four proteins (cytochrome b5, and
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Spot 
No.
Protein
Mr (kDa) /pI
Acce-
ssion 
No.
Sequence
Coverage
(%)*
Protein Name
Down-regulated proteins in allergic asthma
1
� Transthyretin 13.6/5.8 P07309 51
2 Peroxiredoxin 2 21.9/5.2 Q61171 39
3 Myosin light chain 2 18.4/4.4 P51667 52
4 Thioether S-methyltransferase 30.1/6.0 P40936 26
5 Cytochrome b-5 15.2/4.9 P56395 48
Up-regulated proteins in allergic asthma
6 Rho, GDP dissociation inhibitor 22.8/4.9 Q61599 46
(GDI) 
7 Myosin binding protein C, cardiac 21.2/5.5 O70468 37
8 Transthyretin 13.6/5.8 P07309 51
9 Peroxiredoxin 1 22.4/8.6 P35700 42
10 Chitinase 3-like 3 (YM1) 42.6/5.3 P70201 38
11 Ferritin L chain 20.7/5.6 P29391 41
12 -galactoside binding protein 15.1/5.3 P16045 47
13 Fatty acid binding protein 5,  15.5/6.1 Q05816 35
epidermal
14 Peroxiredoxin 6 24.9/5.7 O08709 36
15 Chitinase 3-like 4 (YM2) 45.3/5.8 Q91Z98 41
Table 1. Differentially expressed proteins in the lungs of mice
with OVA-induced allergic asthma
*Sequencing coverage is defined as the percentage of the whole length
of the protein sequence which is covered by matched peptides identi-
fied by the MALDI-TOF MS analysis, 
� Spots shown in Fig. 2.
Fig. 5. RT-PCR analysis
of the mRNA expression
of differentially express-
ed YM proteins. Primers
specific for YM1 and
YM2 were used as indi-
cated to amplify the tran-
scripts from total RNA
isolated from normal and
asthmatic lung tissues.
RT-PCR of the house-
keeping gene GAPDH
was used to control for
RNA variation (bottom).
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Sham Ova
YM2
GAPDHperoxiredoxins 1, 2, and 6) are thought to be related to oxi-
dation and reduction. As antioxidant enzymes in humans,
peroxiredoxins appear to be involved in the redox regulation
of cellular signaling and differentiation, displaying opposing
effects (24). Our 2-DE data showed that peroxiredoxin 2 was
down-regulated and peroxiredoxins 1 and 6 were up-regulat-
ed in asthmatic mouse lungs compared with normal lungs.
This result suggests that oxidants play an important role in
the development of asthma.
Hegesh et al. (25) reported that cytochrome b5 levels were
very low in the red blood cells of a patient with congenital
methemoglobinemia, but were normal in the healthy unrelat-
ed parents and in the patient’s siblings. This finding confirmed
the conclusion of Hultquist and Passon (26) that cytochrome
b5 is required for methemoglobin reduction in vivo. The reduc-
tase converts ferric cytochrome b5 to ferrous cytochrome b5;
the latter then converts methemoglobin (ferric hemoglobin)
to normal hemoglobin (ferrous Hb). These reports together
with our findings in the lungs of mice with experimental
asthma suggest that the decreased levels of cytochrome b5
might be related to the increases in methemoglobin in the
lung tissues of asthmatic patients.
Three other differentially expressed proteins (rho-GDP dis-
sociation inhibitor-beta, myosin light chain 2, and myosin
binding protein C) can be classified as structural proteins
(27, 28). Airway remodeling is a term used to describe the
dynamic processes that lead to structural changes in the air-
ways of patients with asthma. These structural changes are
thought to result in an irreversible component of the airway
obstruction seen in asthma and perhaps also in the develop-
ment of airway hyperresponsiveness. The dynamic processes
underlying these structural changes are viewed as injury-repair
processes driven by airway inflammation. Although the con-
cept of airway remodeling and its role in chronic persistent
airflow obstruction is widely accepted, it should be recognized
that airway remodeling is still just a concept (27). Numerous
histopathologic abnormalities have been described in asth-
matic airways, and yet the functional consequences of these
abnormalities and their role in the natural history of asthma
remain unknown. In this context, we consider that cytoskele-
ton-related proteins such as myosin light chain 2 and myosin
binding protein C might be directly involved with airway
remodeling. Rho-GDP dissociation inhibitor-beta was also
differentially expressed during the process of angiogenesis,
which may indicate a link between its up-regulation in asth-
ma and the cellular proliferation and migration events that
are required for angiogenesis and vascular remodeling (28).
YM1 and YM2 were the most interesting among the iden-
tified proteins. According to our 2-DE, the protein spots for
YM1 and YM2 were scarcely detectable in normal mice. In
contrast, these two protein spots were dramatically up-reg-
ulated in asthmatic mouse lung tissues. The semi-quantita-
tive RT-PCR results (Fig. 5) established that the 2-DE find-
ings reflected increased gene transcription of YM1 and YM2.
These findings were consistent with a previous report (29)
demonstrating that both TH2 cytokines and allergic chal-
lenge both induced YM1 expression in macrophages by a
STAT6-dependent mechanism. YM proteins are thought to
be bi-functional with roles in eosinophil chemotaxis and tis-
sue remodeling (30). More recently, Zhu et al. (31) reported
that acidic mammalian chitinase (AMCase), a human homo-
logue of YM1 and YM2, was induced via an interleukin-13
mediated pathway in epithelial cells and macrophages in an
aeroallergen model and was expressed in very large quantities
in human asthma. In addition, the neutralization of AMCase
ameliorated Th2 inflammation and airway hyperresponsive-
ness (31).
In summary, we used 2-DE to identify proteins that are
differentially expressed in normal and allergic asthmatic mouse
lung tissues. Most of the identified proteins are related to oxi-
dation-reduction and airway remodeling, which may provide
an important connection to the thickening of airway walls
observed in the allergic lung. Recently, many reports demon-
strated associations between the expression of certain proteins
and asthma. However, a comparative analysis of the total pro-
tein profiles for allergic asthmatic and normal lung tissues
has not been reported. Our data suggest that the identified
proteins may provide tools for gauging the success of thera-
peutic interventions designed to reduce the chronic inflam-
mation underlying asthma.
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